Yixintang (002727): The number of stores is rapidly increasing, and offline and online businesses are developing together
Incident: The company released its 2023 annual report and 2024 quarterly report. In 2023, it achieved revenue of 17.380 billion yuan, a year-on-year decrease of 0.29%; net profit to mother was 549 million yuan, a year-on-year decrease of 45.60%;
Yixintang (002727): The next uphill store is expected to drive the performance to improve quarter by quarter
Key investment events: The company announced that in 2023, it achieved revenue of 17.380 billion yuan (-0.29%, indicating year-on-year growth rate, same below), net profit to mother of 549 million yuan (-45.60%), net profit not attributable to mother7
Yixintang (002727): The growth rate of Q1 revenue and store opening increased, and the business trend was good
Introduction to this report: 2023 results are pressured by the impact of the base figure and external environment. The 2024Q1 revenue growth rate has shown a recovery trend, and the growth rate of store openings has also increased, and it is expected to develop steadily throughout the year. Key investment points: Maintain an increase in holdings rating. 2 02
One-off tax supplement of over 200 million yuan Yixintang's net profit fell by more than 40% last year|Financial Report Interpretation
① In 2023, the company's revenue and net profit declined by 0.29% and 45.61%, respectively. ② The total amount of corporate tax supplements and tax arrears last year was about 240 million yuan. ③ The company determines that this tax supplement is a profit and loss caused by a one-time accident and included in non-recurring profit and loss.
Yixintang (002727.SZ): Net profit of 242 million yuan in the first quarter increased 1.03% year over year
On April 26, Ge Longhui (002727.SZ) released its report for the first quarter of 2024. Operating income for the reporting period was 5,0995 million yuan, up 14.96% year on year; net profit attributable to shareholders of listed companies was 242 million yuan, up 1.03% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 246 million yuan, up 2.14% year on year; basic earnings per share were 0.4059 yuan.
Express News | Zheshang Securities: Accelerating the expansion and integrated implementation of pharmacy chains
Isshintang (002727): Steady expansion of stores to strengthen fine management capabilities
The pace of store expansion is steady, and the number is in line with expectations. According to the company's 23-year performance report, as of the end of 23, the company had 10,255 direct-run chain stores and opened 1,381 new stores throughout the year, a net increase of 1,049, 23Q
Yixintang (002727.SZ): Henan Yixintang plans to invest to obtain a controlling interest in Yixintang State Control
Gelonghui, March 18, 丨 Yixintang (002727.SZ) announced that the company held the 7th meeting of the 6th board of directors on March 18, 2024 to review and pass the “Proposal on Foreign Investment by Henan Hongxiang Yixintang Pharmaceutical Co., Ltd., a wholly-owned subsidiary, to acquire a controlling interest in Yixintang State Control Pharmacy Henan Chain Co., Ltd.” (“Henan Yixintang”) for foreign investment to obtain a controlling interest in Yixintang State Control Pharmacy Henan Chain Co., Ltd. (“Henan Yixintang”). Among them: Henan Yixintang received 558.663 million yuan with its own capital
Yixintang (002727.SZ): Shanxi Yixintang plans to acquire the assets and inventory of 21 Xinjinniu pharmacies for no more than 36 million yuan
Gelonghui, March 18 | Yixintang (002727.SZ) announced that according to the business positioning and development plan of Yixintang Pharmaceutical Group Co., Ltd., the company's wholly-owned subsidiary, Shanxi Hongxiang Yixintang Pharmaceutical Co., Ltd. (“Shanxi Yixintang”) plans to acquire 21 store assets and inventory held by Shanxi Xinjinniu Pharmacy Pharmaceutical Chain Co., Ltd. (“Xinjinniu” for short) for no more than 36 million yuan, of which no more than 30 million yuan will be used to pay store transfer fees and purchase subsidiary assets (excluding inventory), and no more than 6 million yuan to purchase stores Inventory products (physical assets belonging to them
Yixintang (002727.SZ) net profit of 549 million yuan in 2023 decreased by 45.61% year-on-year
Yixintang (002727.SZ) released its 2023 annual performance report. During the reporting period, the company achieved operating income of 1...
Isshintang (002727.SZ) plans to acquire a controlling interest in Yixintang Health and increase capital
Yixintang (002727.SZ) issued an announcement to meet the needs of the company's strategic development and guarantee that the company is in Henan Province...
Guojin Securities: The outflow of medical prescriptions is accelerating, and we are optimistic about the strongest companies, Hengqiang
Leading pharmaceutical companies have a higher degree of store compliance and stronger management capabilities. Because they are more supervised and trusted, they are expected to gain a larger share in the process of undertaking the outflow of prescriptions; leading companies have scale effects and are more advantageous in terms of brand, procurement and bargaining power, and logistics management level.
Yixintang (002727.SZ): Chongqing Yixintang plans to acquire the assets and inventory of 24 stores of Chongqing Tongtian Pharmaceutical Co., Ltd. for no more than 21.1 million yuan
Gelonghui, December 27丨Yixintang (002727.SZ) announced that according to the business positioning and development plan of Yixintang Pharmaceutical Group Co., Ltd., its wholly-owned subsidiary Chongqing Hongxiang Yixintang Pharmaceutical Co., Ltd. (“Chongqing Yixintang”) plans to acquire 24 store assets and inventory held by Chongqing Tongtian Pharmaceutical Co., Ltd. (“Tongtian Pharmaceutical” for short) for no more than RMB 21.1 million, of which no more than RMB 17.1 million will be used to pay store transfer fees and purchase subsidiary assets (excluding inventory), and no more than 4 million yuan to purchase in-store inventory products (excluding inventory) Part root of physical assets and inventory
Guojin Securities: The outflow of prescriptions brings incremental space to the industry, optimistic about leading retail pharmacies
Prescription outflow, also known as prescription distribution, refers to the act of patients diagnosing and treating a disease in a hospital. After the doctor prescribes drugs according to the treatment plan, they do not distribute prescriptions at the hospital pharmacy, but choose to distribute prescriptions at social pharmacies.
Yixintang (002727.SZ) received a total increase in holdings of 46,700 shares from the two senior executives
Yixintang (002727.SZ) announced that Zhang Yong, director and executive president of the company, and Xiao Donglei, head of finance, competed...
Yishintang (002727.SZ): Director, Executive President and Head of Finance increased their holdings of the company's shares
Gelonghui announced on December 22丨Yixintang (002727.SZ) announced that it has received notifications from Mr. Zhang Yong, director and executive president of the company, and Mr. Xiao Donglei, head of finance. Based on their confidence in the company's future development prospects and approval of the company's values, Mr. Zhang Yong and Mr. Xiao Donglei have increased their shares in the company through centralized bidding through the trading system of the Shenzhen Stock Exchange. Zhang Yong has now increased his holdings by 23,800 shares, and Xiao Donglei has increased his holdings by 22,900 shares.
Yixintang (002727.SZ) appoints Zhang Yong as executive president
Yixintang (002727.SZ) issued an announcement. According to the needs of the company's management work, the nomination committee of the company's board of directors...
Yishintang (002727) 2023 Three Quarter Report Commentary: Short-term performance pressure is expected to gradually resume
Matters: The company released its 2023 three-quarter report. The company's revenue was 12.813 billion yuan (+6.55%), and net profit was 686 million yuan (+1.26%). In the third quarter alone, the company's revenue was 4.137 billion
The pharmaceutical commercial sector continues to rise, and Yixintang rises and stops
Gelonghui November 10 | Yixintang rose and stopped, and ordinary people, Jianzhijia, Easy Purchase of Medicine, and Runda Healthcare followed suit.
Pharmaceutical commercial stocks fluctuated and rebounded
Gelonghui November 10 | Yixintang rose more than 7%, and Celi Healthcare, Ordinary People, Jianzhijia, Yifeng Pharmacy, and Dashenlin followed suit.
No Data